RiceBran Technologies (RIBT) 10-Q 13 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	13-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	RiceBran Technologies
Entity Central Index Key	1063537
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		9,386,822
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements of Operations (Unaudited) [Abstract]
Revenues	$9,659	$7,684
Cost of goods sold	8,605	6,270
Gross profit	1,054	1,414
Operating expenses:
Selling, general and administrative	3,487	3,315
Depreciation and amortization	505	818
Total operating expenses	3,992	4,133
Income (loss) from operations	-2,938	-2,719
Other income (expense):
Interest income	49	15
Interest Expense	-799	-1,188
Change in fair value of derivative warrant and conversion liabilities	173	2,058
Foreign currency exchange, net	-219	75
Financing expense	0	-1,122
Other income	157	46
Other expense	-75	-198
Total other income (expense)	-714	-314
Loss before income taxes	-3,652	-3,033
Income tax benefit	6	248
Net loss	-3,646	-2,785
Net loss attributable to noncontrolling interest in Nutra SA	644	920
Net loss attributable to RiceBran Technologies shareholders	($3,002)	($1,865)
Loss per share attributable to RiceBran Technologies shareholders
Basic (in dollars per share)	($0.33)	($0.62)
Diluted (in dollars per share)	($0.33)	($0.62)
Weighted average number of shares outstanding
Basic (in shares)	9,154,134	3,017,408
Diluted (in shares)	9,154,134	3,017,408

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) [Abstract]
Net loss	($3,646)	($2,785)
Other comprehensive loss - foreign currency translation, net of tax	-1,417	372
Comprehensive loss, net of tax	-5,063	-2,413
Comprehensive loss attributable to noncontrolling interest, net of tax	1,125	752
Total comprehensive loss attributable to RiceBran Technologies shareholders	($3,938)	($1,661)

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$1,249	$3,610
Restricted cash	1,920	1,920
Accounts receivable, net of allowance for doubtful accounts of $512 and $574 (variable interest entity restricted $1,727 and $1,980)	2,703	3,055
Inventories	4,270	3,508
Income and operating taxes recoverable	745	737
Deferred tax asset	171	171
Deposits and other current assets	909	1,071
Total current assets	11,967	14,072
Property, net (variable interest entity restricted $2,945 and $3,727)	21,436	24,753
Goodwill	3,796	4,431
Intangible assets, net	2,298	2,740
Other long-term assets	158	88
Total assets	39,655	46,084
Current liabilities:
Accounts payable	3,300	3,286
Accrued salary, wages and benefits	2,258	2,206
Accrued expenses	4,652	4,257
Other liabilities	716	573
Current maturities of debt (variable interest entity nonrecourse $3,877 and $4,758)	3,931	4,808
Total current liabilities	14,857	15,130
Long-term debt, less current portion (variable interest entity nonrecourse $5,022 and $6,203)	10,297	11,288
Deferred tax liability	391	396
Derivative warrant liabilities	782	955
Total liabilities	26,327	27,769
Commitments and contingencies
Temporary equity:
Temporary Equity - Redeemable noncontrolling interest in Nutra SA	1,376	2,643
Equity attributable to RiceBran Technologies shareholders:
Preferred stock, 20,000,000 shares authorized and none issued	0	0
Common stock, no par value, 25,000,000 shares authorized, 9,386,822 and 9,383,571 shares issued and outstanding	261,518	261,299
Accumulated deficit	-245,472	-242,470
Accumulated other comprehensive loss	-4,094	-3,157
Total equity attributable to RiceBran Technologies shareholders	11,952	15,672
Total liabilities, temporary equity and equity	$39,655	$46,084

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Current assets:
Accounts receivable, allowance for doubtful accounts	$512	$574
Equity attributable to RiceBran Technologies shareholders:
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$0	$0
Common stock, shares authorized (in shares)	25,000,000	25,000,000
Common stock, shares issued (in shares)	9,386,822	9,383,571
Common stock, shares outstanding (in shares)	9,386,822	9,383,571
Variable Interest Entity [Member]
Current assets:
Accounts receivable, variable interest entity restricted	1,727	1,980
Variable interest entity restricted portion of property, net	2,945	3,727
Current liabilities:
Nonrecourse portion of current maturities of long-term debt	3,877	4,758
Long-term liabilities:
Long-term debt, less current portion variable interest entity nonrecourse	$5,022	$6,203

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flow from operating activities:
Net loss	($3,646)	($2,785)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,162	1,495
Stock and share-based compensation	219	78
Change in fair value of derivative warrant and conversion liabilities	-173	-2,058
Financing expense	0	1,122
Deferred tax benefit	-6	-248
Interest accreted	208	271
Other	59	54
Changes in operating assets and liabilities:
Accounts receivable	-31	678
Inventories	-871	-551
Accounts payable and accrued expenses	1,294	533
Other	-180	-138
Net cash used in operating activities	-1,965	-1,549
Cash flows from investing activities:
Acquisition of HN, net of cash acquired	0	-725
Purchases of property	-307	-2,203
Proceeds from sale of property	0	20
Net cash used in investing activities	-307	-2,908
Cash flows from financing activities:
Payments of debt	-3,886	-4,782
Proceeds from issuance of debt, net of issuance costs	3,721	4,258
Redemption of stock	0	-450
Proceeds from issuance of convertible debt and related warrants, net of costs	0	4,303
Proceeds from issuance of common stock and warrants, net of costs	0	764
Net cash provided by (used in) financing activities	-165	4,093
Effect of exchange rate changes on cash and cash equivalents	76	71
Net change in cash and cash equivalents	-2,361	-293
Cash and cash equivalents, beginning of period	3,610	5,091
Cash and cash equivalents, end of period	1,249	4,798
Supplemental disclosures:
Cash paid for interest	441	580
Cash paid for income taxes	$0	$0

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2015
BASIS OF PRESENTATION [Abstract]
BASIS OF PRESENTATION	NOTE 1. BASIS OF PRESENTATION
	In the opinion of management, the accompanying unaudited condensed consolidated financial statements of RiceBran Technologies and subsidiaries were prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q; therefore, as permitted under these rules, certain footnotes and other financial information included in audited financial statements were condensed or omitted.  The interim financial statements contain all adjustments necessary to present fairly the interim results of operations, financial position and cash flows for the periods presented.
	These interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2014. The report of our independent registered public accounting firm that accompanies the audited consolidated financial statements for the year ended December 31, 2014, included in that Annual Report on Form 10-K, contains a going concern explanatory paragraph in which our independent registered public accounting firm expressed substantial doubt about our ability to continue as a going concern.  The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.
	The interim results reported in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for the full fiscal year, or any other future period, and have been prepared assuming we will continue as a going concern based on the realization of assets and the satisfaction of liabilities in the normal course of business.
	Certain reclassifications have been made to amounts reported for the prior year to achieve consistent presentation with the current year.
	Recent Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers, which supersedes current revenue recognition guidance and most industry-specific guidance.  Under the new standard we will recognize revenue from the transfer of goods or services to customers in amounts that reflect the consideration to which we expect to be entitled in exchange for those goods or services.  Revenue from a contract that contains multiple performance obligations will be allocated to each performance obligation generally on a relative standalone selling price basis.  The guidance is effective for our annual and interim periods beginning in 2017.  Early adoption is prohibited.  We have not yet determined the impact that the new guidance will have on our results of operations and financial position and have not yet determined the method by which we will adopt the standard in 2017.
	In February 2015, the FASB issued guidance which makes targeted amendments to current consolidation guidance.  Among other things, the standard changes the manner in which we would assess one of the characteristics of variable interest entities (VIEs) and introduces a separate analysis specific to limited partnerships and similar entities (such as Nutra SA) for assessing if the equity holders at risk lack decision making.  Limited partnerships and similar entities will be a VIE unless the limited partners hold substantive kick-out rights or participating rights.  A right to liquidate an entity is akin to a kick-out right.  Guidance for limited partnerships under the voting model has been eliminated.  A limited partner and similar partners with a controlling financial interest obtained through substantive kick-out rights would consolidate a limited partnership or similar entity. The guidance is effective for our annual and interim periods beginning in 2016.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations and financial position and have not yet determined if we will early adopt the standard.
	In April 2015, the FASB issued guidance on the presentation and disclosure of debt issuance costs. The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015. Early adoption permitted for financial statements that have not been previously issued. The adoption of this statement will impact future presentation and disclosures of the financial statements.

BUSINESS

BUSINESS	3 Months Ended
	Mar. 31, 2015
BUSINESS [Abstract]
BUSINESS	NOTE 2. BUSINESS
	We are a human food ingredient, nutritional supplement and animal nutrition company focused on value-added processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran (RRB), an underutilized by-product of the rice milling industry.  Using our bio-refining business model, we apply our proprietary and patented technologies and intellectual properties to convert RRB into numerous high value products including stabilized rice bran (SRB), rice bran oil (RBO), defatted rice bran (DRB), RiBalance (a complete rice bran nutritional package derived from further processing of SRB), RiSolubles (a highly nutritious, carbohydrate and lipid rich fraction of SRB), RiFiber (a fiber rich derivative of SRB), ProRyza rice bran protein-based products and a variety of other valuable derivatives extracted from these core products.  Our target markets are natural food, functional food, nutraceutical supplement and animal nutrition manufacturers, wholesalers and retailers, both domestically and internationally.
	We have two reportable operating segments: (i) USA segment, which manufactures and distributes SRB in various granulations along with Stage II products (described below) and derivatives and formulates and co-packages products and (ii) Brazil segment, which extracts crude RBO and DRB from rice bran, which are then further processed into fully refined rice bran oil for sale internationally and in Brazil, compounded animal nutrition products and a number of valuable human food and animal nutrition products derivatives and co-products. In addition we incur corporate and other expenses not directly attributable to operating segments, which include costs related to our corporate staff, general and administrative expenses including public company expenses, intellectual property, professional fees, and other expenses.  No corporate allocations, including interest, are made to the operating segments.
	The combined operations of our USA and Brazil segments encompass our bio-refining approach to processing RRB into various high quality, value-added constituents and finished products.  Over the past decade, we have developed and optimized our proprietary bio-refining processes to support the production of healthy, natural, hypoallergenic, gluten free, and non-genetically modified ingredients and supplements for use in human meats, baked goods, cereals, coatings, health foods, nutritional supplements, nutraceuticals and high-end animal nutrition and health products.
	The USA segment produces SRB inside two supplier rice mills in California and one owned facility in Louisiana.  A facility located in Lake Charles, Louisiana has been idle since May 2009.  The USA segment also includes our Dillon, Montana Stage II facility which produces our Stage II products RiSolubles (a highly nutritious, carbohydrate and lipid rich fraction of SRB), RiFiber (a fiber rich derivative of SRB), RiBalance (a complete rice bran nutritional package derived from further processing SRB), and ProRyza, a family of protein products.  Stage II refers to the proprietary processes run at our Dillon, Montana facility and includes products produced at that facility using our patented processes.  In January 2014, we completed the acquisition of H&N Distribution Inc., now operating as Healthy Natural, Inc. (HN), which has been integrated into our USA segment.  HN is a formulator and co-packer of products targeted at customers in the direct marketing, internet sales and retail distribution markets, and operates a facility in Irving, Texas. HN serves the natural products, nutritional supplement and nutraceutical and functional food sectors.  We acquired HN as part of our strategy to vertically integrate our business in order to leverage our proprietary and patented technologies.  Certain manufacturing facilities included in our USA segment have proprietary processing equipment and patented technology for the stabilization and further processing of rice bran into finished products.  In the three months ended March 31, 2015, approximately 81% of USA segment revenue was from sales of human food products and the remainder was from sales of animal nutrition products.
	The Brazil segment consists of the consolidated operations of Nutra SA, whose only operating subsidiary is Irgovel, located in Pelotas, Brazil.  Irgovel manufactures RBO and DRB products for both the human ingredient and animal nutrition markets in Brazil and internationally.  In refining RBO to an edible grade, several co-products are obtained.  One such product is distilled fatty acids, a valuable raw material for the detergent industry.  Irgovel recently started production of rice lecithin, which has application in human nutrition, animal nutrition and industrial applications.  DRB is compounded with a number of other ingredients to produce complex animal nutrition products which are packaged and sold under Irgovel brands in the Brazilian market, sold as a raw material for further processing into human food ingredients or sold in bulk into the animal nutrition markets in Brazil and neighboring countries.  In 2014, approximately 39% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.  In the three months ended March 31, 2015, approximately 47% of Brazil segment product revenue was from sales of RBO products and the remainder was from sales of DRB products.

LIQUIDITY_AND_MANAGEMENTS_PLAN

LIQUIDITY AND MANAGEMENT'S PLAN	3 Months Ended
	Mar. 31, 2015
LIQUIDITY AND MANAGEMENT'S PLAN [Abstract]
LIQUIDITY AND MANAGEMENT'S PLAN	NOTE 3. LIQUIDITY AND MANAGEMENT’S PLAN
	In 2014 and the first three months of 2015, we continued to experience losses and negative cash flows from operations which raises substantial doubt about our ability to continue as a going concern.  We believe that we will be able to obtain additional funds to operate our business, should it be necessary, however, there can be no assurances that our efforts will prove successful.  The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.
	As described further in Note 5, in January 2014, we completed the acquisition of HN, the operations of which are accretive to cash flows.  Our Brazilian subsidiary, Industria Riograndens De Oleos Vegetais Ltda. (Irgovel), recently completed the final stages of a major capital expansion.  Significant cash was used during the shutdown period.  Operations at Irgovel are expected to improve during the second quarter of 2015, such that Irgovel should be operating at its targeted capacity. However, there are no assurances that this will occur.
	On May 12, 2015, we entered into an $8 million senior secured credit facility agreement consisting of a $3.5 million maximum working capital revolver and two term loan tranches.

LOSS_PER_SHARE_EPS

LOSS PER SHARE (EPS)	3 Months Ended
	Mar. 31, 2015
LOSS PER SHARE (EPS) [Abstract]
LOSS PER SHARE (EPS)	NOTE 4. LOSS PER SHARE (EPS)
	Basic EPS is computed by dividing net income (loss) attributable to RiceBran Technologies shareholders by the weighted average number of common shares outstanding during all periods presented.  Shares underlying options, warrants and convertible debt are excluded from the basic EPS calculation but are considered in calculating diluted EPS.  Nonvested shares that vest solely on the basis of a service condition are not included in the denominator of the computation of basic EPS.
	Diluted EPS is computed by dividing the net income (loss) attributable to RiceBran Technologies shareholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding if the impact of assumed exercises and conversions is dilutive.  The dilutive effect of outstanding options and warrants is calculated using the treasury stock method.  The dilutive effect of outstanding convertible debt is calculated using the if-converted method.  Nonvested shares that vest solely on the basis of a service condition are included in the denominator of the computation of diluted EPS during their requisite service period under the treasury stock method.
	Below are reconciliations of the numerators and denominators in the EPS computations for the three months ended March 31, 2015 and 2014.
		2015			2014
	NUMERATOR (in thousands):
	Basic and diluted - net loss attributable to RiceBran Technologies shareholders	$	(3,002	)	$	(1,865	)
	DENOMINATOR:
	Basic EPS - weighted average number of shares outstanding		9,154,134			3,017,408
	Effect of dilutive securities outstanding		-			-
	Diluted EPS - weighted average number of shares outstanding		9,154,134			3,017,408
	Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive-
	Stock options (average exercise price of $11.48 and $24.52)		264,305			174,141
	Warrants  (average exercise price of $5.77 and $6.27)		6,503,959			2,750,335
	Nonvested stock		224,967			-
	The impact of potentially dilutive securities outstanding at March 31, 2015 and 2014, was not included in the calculation of diluted EPS for the three months ended March 31, 2015 and 2014 because to do so would be antidilutive.  Those securities listed in the table above which were antidilutive for the periods presented, which remain outstanding, could potentially dilute EPS in the future.

HN_ACQUISITION

H&N ACQUISITION	3 Months Ended
	Mar. 31, 2015
H&N ACQUISITION [Abstract]
H&N ACQUISITION	NOTE 5. HN ACQUISITION
	In January 2014, we purchased all of the outstanding shares of HN for $2.0 million in cash ($1.8 million paid in January 2014 and $0.2 million payable upon the resolution of certain contingencies) and promissory notes in the face amount of $3.3 million, subject to working capital adjustments.  HN is an Irving, Texas-based formulator and co-packer of products targeted at customers in the direct marketing, internet sales and retail distribution markets. HN serves the natural products, nutritional supplement and nutraceutical and functional food sectors.  We acquired HN as part of our strategy to vertically integrate our business in order to leverage our proprietary and patented technologies.  The acquisition has been accounted for as a business combination.  The results of HN’s operations are included in our consolidated financial statements beginning January 2, 2014, and are included in our USA segment.
	In the first quarter of 2014, we incurred $0.3 million of acquisition-related costs which are included in selling, general and administrative expenses in the consolidated statements of operations.  The following table summarizes the aggregate purchase price allocation, the consideration transferred to acquire HN, as well as the amounts of identified assets acquired and liabilities assumed based on the estimated fair value as of the January 2, 2014, acquisition date (in thousands).
	Cash	$	1,800
	Cash holdback for contingencies		200
	Convertible notes payable		2,785
	Total fair value of consideration transferred		4,785
	Financial assets, including acquired cash of $1,075		1,314
	Inventories		1,109
	Property		963
	Identified intangible asset estimate		3,847
	Deferred  income taxes, net		(1,529	)
	Financial liabilities		(1,709	)
	Net recognized amounts of identifiable assets acquired		3,995
	Goodwill - USA segment	$	790
	The terms of the convertible notes payable are further discussed in Note 10.  The fair value of trade receivables at January 2, 2014, was $0.1 million which equaled the gross amount receivable.  We have assigned a $3.8 million value to a customer relationship intangible and we are amortizing that intangible over a three year period as follows: $1.7 million in 2014, $1.3 million in 2015 and $0.8 million in 2016.  In the three months ended March 31, 2015, we recognized $0.3 million of amortization expense in the USA segment related to this intangible.
	Our consolidated revenues include $2.5 million of HN revenues for the three months ended March 31, 2014. After making a reasonable effort, we have been unable to determine net income (loss) attributable to HN resulting from it being fully integrated into the USA segment during 2014.

REDEEMABLE_NONCONTROLLING_INTE

REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA	3 Months Ended
	Mar. 31, 2015
REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA [Abstract]
REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA	NOTE 6. REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA
	We hold a variable interest which relates to our equity interest in Nutra SA, LLC (Nutra SA).  We are the primary beneficiary of Nutra SA, and as such, Nutra SA’s assets, liabilities and results of operations are included in our consolidated financial statements.  The other equity holders’ interests are reflected in net loss attributable to noncontrolling interest in Nutra SA, in the consolidated statements of operations, and redeemable noncontrolling interest in Nutra SA, in the consolidated balance sheets.  Our variable interest in Nutra SA is our Brazil segment.  A summary of the carrying amounts of Nutra SA balances included in our consolidated balance sheets follows (in thousands).
		March 31,			December 31,
		2015			2014
	Cash and cash equivalents	$	37		$	269
	Other current assets (restricted $1,727 and $1,980)		4,286			4,735
	Property, net (restricted $2,945 and  $3,727)		12,085			15,258
	Goodwill and intangibles, net		3,006			3,722
	Other noncurrent assets		29			34
	Total assets	$	19,443		$	24,018
	Current liabilities	$	5,637		$	5,346
	Current portion of long-term debt (nonrecourse)		3,877			4,758
	Long-term debt, less current portion (nonrecourse)		5,022			6,203
	Total liabilities	$	14,536		$	16,307
	Nutra SA’s debt is secured by its accounts receivable and property.  The non-Brazilian entities in our consolidated group do not guarantee any of Nutra SA’s debt.
	A summary of changes in redeemable noncontrolling interest in Nutra SA follows for the three months ended March 31, 2015 and 2014 (in thousands).
		2015			2014
	Redeemable noncontrolling interest in Nutra SA, beginning of period	$	2,643		$	7,177
	Investors' interest in net loss of Nutra SA		(644	)		(920	)
	Investors' interest in other comprehensive loss of Nutra SA		(481	)		168
	Accumulated Yield classified as other current liability		(142	)		-
	Redeemable noncontrolling interest in Nutra SA, end of period	$	1,376		$	6,425
	Investors' average interest in Nutra SA		34.2	%		45.2	%
	In December 2010, we entered into a membership interest purchase agreement (MIPA) with AF Bran Holdings-NL LLC and AF Bran Holdings LLC (Investors).  As of March 31, 2015 and December 31, 2014, the Investors interest was 33.9% and 34.7%.  In the three months ended March 31, 2015, we invested an additional $1.1 million in Nutra SA.  We invested an additional $0.2 million in Nutra SA between April 1, 2015, and May 13, 2015.  The Investors’ share of Nutra SA’s net income (loss) increases (decreases) redeemable noncontrolling interest.  We are restricted from competing with Nutra SA and Irgovel in Brazil as further described in the MIPA.
	Redeemable noncontrolling interest in Nutra SA is recorded in temporary equity, above the equity section and after liabilities on our consolidated balance sheets, because the Investors have drag along rights which provide the Investors the ability to force a sale of Nutra SA assets in the future.  We have assessed the likelihood of the Investors exercising these rights as less than probable at March 31, 2015.  We will continue to evaluate the probability of the Investors exercising their drag along rights each reporting period.  We will begin to accrete the redeemable noncontrolling interest up to fair value if and when it is probable the Investors will exercise these rights.
	Under the limited liability company agreement for Nutra SA (LLC agreement), as amended, any units held by the Investors beginning January 1, 2014, accrue a yield at 4% (Yield).  Commencing with the first quarter of 2014, Nutra SA must make distributions to the Investors quarterly in the amount equal to the previously accrued and unpaid Yield plus any additional distributions owed to the Investors, to the extent there is distributable cash, as defined in the LLC agreement.  As of March 31, 2015, our balance sheet includes an other liability of $0.7 million for Yield accumulated and unpaid.  Nutra SA has made no Yield payments.
	Following the payment of the Yield, Nutra SA must distribute all distributable cash (as defined in the LLC Agreement) to the members on March 31 of each year as follows: (i) first, to the Investors in an amount equal to 2.3 times the Investors’ capital contributions, less the aggregate amount of non-Yield distributions paid to the Investors, (ii) second, to us in an amount equal to twice the capital contributions made by us, less the aggregate amount of distributions paid to us; and (iii) third, to us and the Investors in proportion to our respective membership interests.
	Under the LLC agreement, the business of Nutra SA is to be conducted by the manager, currently our CEO, subject to the oversight of the management committee.  The management committee is comprised of three of our representatives and two Investor representatives.  Upon an event of default or a qualifying event, we will no longer control the management committee and the management committee will include three Investor representatives and two of our representatives.  In addition, following an event of default or a qualifying event, a majority of the members of the management committee may replace the manager of Nutra SA.
	As of March 31, 2015, there have been no unwaived events of default.  Events of default, as defined in the MIPA and the October 2013 amendment of investment agreements, are failure of Irgovel to meet minimum annual processing targets or to achieve EBITDA of at least $4.0 million in any year beginning in 2015.
	As of March 31, 2015, there have been no qualifying events.  The LLC agreement defines a qualifying event as any event prior to September 16, 2014, which results, or will result, in (i) a person or group of persons exercising the right to appoint members to our board of directors holding one third or more of the votes of all board members, (ii) the sale, exchange, pledge or use as guarantee of one half or more of our ownership interest in Nutra SA to a third party or (iii) the bankruptcy of RiceBran Technologies or Nutra SA.
	The Investors have drag along rights, the right to force the sale of all Nutra SA assets after January 1, 2016.  The right terminates upon the occurrence of certain events (a $50 million Nutra SA initial public offering or a change of control, as defined).  We may elect to exercise a right of first refusal to purchase the Investors’ interest instead of proceeding to a sale.
	In evaluating whether we are the primary beneficiary of Nutra SA, we considered the matters which could be put to a vote of the members.  Until there is an event of default or a qualifying event, the Investors’ rights and abilities, individually or in the aggregate, do not allow them to substantively participate in the operations of Nutra SA.  The Investors do not currently have the ability to dissolve Nutra SA or otherwise force the sale of all its assets.  They do have drag along rights in the future.  We will continue to evaluate our ability to control Nutra SA each reporting period.
	Cash provided by operations in our Brazil segment is generally unavailable for distribution to our Corporate and USA segments pursuant to the terms of the LLC agreement.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2015
INVENTORIES [Abstract]
INVENTORIES	NOTE 7. INVENTORIES
	Inventories are composed of the following (in thousands):
		March 31,		December 31,
		2015		2014
	Finished goods	$	2,674	$	1,103
	Work in process		131		380
	Raw materials		966		1,441
	Packaging supplies		499		584
	Total inventories	$	4,270	$	3,508

PROPERTY

PROPERTY	3 Months Ended
	Mar. 31, 2015
PROPERTY [Abstract]
PROPERTY	NOTE 8. PROPERTY
	Property, plant and equipment consist of the following (in thousands):
		March 31,		December 31,
		2015		2014
	Land	$	477	$	364
	Furniture and fixtures		449		539
	Plant		15,631		15,942
	Computer and software		1,871		1,701
	Leasehold improvements		637		568
	Machinery and equipment		22,854		21,519
	Property		41,919		40,633
	Less accumulated depreciation		20,483		15,880
	Property,  net	$	21,436	$	24,753
	Included in accounts payable at March 31, 2015 is $0.1 million related to amounts payable for machinery and equipment additions.

GOODWILL

GOODWILL	3 Months Ended
	Mar. 31, 2015
GOODWILL [Abstract]
GOODWILL	NOTE 9. GOODWILL
	A summary of goodwill activity follows for the three months ended March 31, 2015 and 2014.
		2015			2014
	Goodwill, beginning of period	$	4,431		$	4,139
	USA Segment - Acquisition of H&N		-			675
	Brazil segment - Effect of foreign currency translation		(635	)		179
	Goodwill, end of period	$	3,796		$	4,993

EQUITY_SHAREBASED_COMPENSATION

EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS	3 Months Ended
	Mar. 31, 2015
EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS [Abstract]
EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS	NOTE 10. EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS
	A summary of equity activity for the three months ended March 31, 2015, (in thousands, except share and per share data) follows.
		Common Stock					Accumulated			Accumulated Other Comprehensive			Total
		Shares			Amount		Deficit			Loss			Equity
	Balance, December 31, 2014		9,383,571		$	261,299	$	(242,470	)	$	(3,157	)	$	15,672
	Share-based compensation, employees and directors		-			205		-			-			205
	Other		3,251			14		-			-			14
	Foreign currency translation		-			-		-			(937	)		(937	)
	Net loss		-			-		(3,002	)		-			(3,002	)
	Balance, March 31, 2015		9,386,822		$	261,518	$	(245,472	)	$	(4,094	)	$	11,952
	A summary of stock option and warrant activity for the three months ended March 31, 2015, follows.
		Options								Equity and Liability Warrants
		Shares Under			Weighted		Weighted			Shares Under			Weighted			Weighted
		Options			Average		Average			Warrants			Average			Average
					Exercise		Remaining						Exercise			Remaining
					Price		Contractual						Price			Contractual
							Life (Years)									Life (Years)
	Outstanding, December 31, 2014		269,642		$	12.12		7.9			6,503,959		$	5.77			4.3
	Granted		-			-					-			-
	Exercised		-			-					-			-
	Forfeited, expired or cancelled		(15,000	)		23.18					-			-
	Outstanding, March 31, 2015		254,642		$	11.47		7.7			6,503,959		$	5.77			4.1
	Exercisable, March 31, 2015		144,141		$	16.15		6.4			5,322,264		$	5.88			3.8
	Equity Incentive Plan
	The board of directors adopted our 2014 Equity Incentive Plan in August 2014, after the plan was approved by shareholders.  A total of 1,600,000 shares of common stock were initially reserved for issuance under the plan.  Under the terms of the plan, we may grant options to purchase common stock and shares of common stock to officers, directors, employees or consultants providing services on such terms as are determined by the board of directors.  Our board of directors administers the plan, determines vesting schedules on plan awards and may accelerate the vesting schedules for award recipients.  The options granted under the plan have terms of up to 10 years.
	In the third quarter of 2014, we issued shares of common stock to directors and executive officers at a grant date fair value of $4.91 per share.  We issued 44,026 shares which vested in August 2014, 52,412 shares which vest in August 2015 (or at the next annual shareholder meeting date if earlier) and 185,182 shares which vest in August 2017.  In the first quarter of 2015, we recognized $0.2 million in compensation.  As of March 31, 2015, we expect to recognize the remaining $0.8 million of unrecognized compensation over a weighted average period of 2.2 years.
	Warrants that Contain Antidilution Clauses
	As of March 31, 2015, we have two warrant agreements outstanding (with one holder) that contain antidilution clauses.  The related warrants are classified as derivative warrant liabilities in our balance sheets.  Under the antidilution clauses contained in these warrants, in the event of equity issuances at prices below the exercise prices of these warrants, we may be required to lower the exercise price on these warrants and increase the number of shares underlying these warrants.  Equity issuances may include issuances of our common stock, certain awards of options to employees, and issuances of warrants and/or other convertible instruments.

DEBT

DEBT	3 Months Ended
	Mar. 31, 2015
DEBT [Abstract]
DEBT	NOTE 11. DEBT
	The following table summarizes current and long-term portions of debt (in thousands).
		March 31,		December 31,
		2015		2014
	Corporate segment:
	Subordinated notes, net	$	5,186	$	4,978
	Other		144		157
			5,330		5,135
	Brazil segment:
	Capital expansion loans		2,876		3,629
	Working capital lines of credit		1,811		2,408
	Advances on customer export orders		1,557		1,810
	Special tax programs		2,585		3,016
	Other		69		98
			8,898		10,961
	Total debt		14,228		16,096
	Current portion		3,931		4,808
	Long-term portion	$	10,297	$	11,288
	USA Segment
	As of March 31, 2015, subordinated notes in the principal amount of $6.5 million remain outstanding.  The notes bear interest of 5% per year, payable quarterly, and mature in July 2016.  We are accreting the notes up to their face value at an average annual interest rate of 22.7%.
	Brazil Segment
	All Brazil segment debt is denominated in the Brazilian Real (R$), except advances on customer export orders which are denominated in U.S. Dollars.
	Capital Expansion Loans
	In December 2011, Irgovel entered into loan agreements with the Bank of Brazil.  As of March 31, 2015, the notes held a principal balance of R$7.9 million. The annual interest rate on the loans is 6.5%, payable quarterly and the loans mature December 2021.  Irgovel must make monthly principal payments under each of the loans.  Irgovel used R$1.5 million of the proceeds for working capital purposes and the remainder for the purchase of equipment and machinery.  In July 2012, Irgovel entered into an agreement with the bank under which it borrowed R$1.7 million for the purchase of certain equipment at an annual interest rate of 5.5%.  Interest is payable quarterly on the amounts outstanding and the maturity date of the loans is July 2019.  Irgovel must make monthly principal payments under the loans.  The capital expansion loans are secured by the related equipment.
	Working Capital Lines of Credit
	Irgovel has working capital lines of credit secured by accounts receivable.  The total amount of borrowing cannot exceed 30%-100% of the collateral, depending on the agreement.  The annual interest rates on this debt range from 10.4% to 34.8%, and average 26.2%.  Principal maturities of amounts outstanding extend through September 2019.
	Advances on Customer Export Orders
	Irgovel obtains advances against certain customer export orders from various banks.  The annual interest rates on these advances range from 5.0% to 10.0%, and average 9.6%.  Principal maturities of amounts outstanding extend through 2015.
	Special Tax Programs
	Irgovel has an unsecured note payable for Brazilian federal and social security taxes under special Brazilian government tax programs.  Principal and interest payments are due monthly through January 2029.  Interest on the notes is payable monthly at the Brazilian SELIC target rate, which was 12.8% at March 31, 2015.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 12. COMMITMENTS AND CONTINGENCIES
	In addition to the matters discussed below, from time to time we are involved in litigation incidental to the conduct of our business.  When applicable, we record accruals for contingencies when it is probable that a liability will be incurred and the amount of loss can be reasonably estimated.  While the outcome of lawsuits and other proceedings against us cannot be predicted with certainty, in the opinion of management, individually or in the aggregate, no such lawsuits are expected to have a material effect on our financial position or results of operations.
	Defense costs are expensed as incurred and are included in professional fees.
	Irgovel Purchase
	On August 28, 2008, former Irgovel stockholder David Resyng filed an indemnification suit against Irgovel, Osmar Brito and the remaining former Irgovel stockholders (Sellers), requesting:  (i) the freezing of the escrow account maintained in connection with the transfer of Irgovel’s corporate control to us and the presentation of all documentation related to the transaction, and (ii) damages in the amount of the difference between (a) the sum received by David Resyng in connection with the judicial settlement agreement executed in the action for the partial dissolution of the limited liability company filed by David Resyng against Irgovel and the Sellers and (b) the amount received by the Sellers in connection with the sale of Irgovel’s corporate control to us, in addition to moral damages as determined in the court’s discretion.  The amount of damage claimed by Mr. Resyng is approximately $3 million.
	We believe that the filing of the above lawsuit is a fundamental default of the obligations undertaken by the Sellers under the Quotas Purchase Agreement for the transfer of Irgovel’s corporate control, executed by and among the Sellers and us on January 31, 2008 (Purchase Agreement).  Consequently, we believe that the responsibility for any indemnity, costs and expenses incurred or that may come to be incurred by Irgovel and/or us in connection with the above lawsuit is the sole responsibility of the Sellers.
	On February 6, 2009, the Sellers filed a collection lawsuit against us seeking payment of the second installment of the purchase price under the Purchase Agreement, which the Sellers assert is approximately $1.0 million.  We have withheld payment of the second installment pending resolution of the Resyng lawsuit noted above.  Our parent company has not been served with any formal notices in regard to this matter.  To date, only Irgovel has received formal legal notice.  In addition, the Purchase Agreement requires that all disputes between us and the Sellers be adjudicated through arbitration.  On October 29, 2010, we initiated an arbitration proceeding against the Sellers for breaches of the Purchase Agreement, including claims related to Sellers’ handling of the Resyng claim and whether any future payments are required under the Purchase Agreement.  On February 25, 2015, the arbitration panel issued its opinion and ordered the Sellers to pay Irgovel and us R$3.6 million plus arbitration fees, legal fees, and interest.  We are currently seeking to confirm and obtain a final award in Brazil.
	As part of the Purchase Agreement, $2.0 million was deposited into an escrow account to cover contingencies with the net remaining funds payable to the Sellers upon resolution of all contingencies.  As of March 31, 2015, the balance in the escrow account was $1.9 million and is included in restricted cash in our balance sheets.  There is an escrow liability related to the lawsuit in accrued expenses on our balance sheets as of March 31, 2015, totaling $1.7 million.  When the escrow account was funded, we established an accrued liability equal to the amount of the escrow for contingencies and the net balance due to the Sellers under the terms of the Purchase Agreement.  As of March 31, 2015, $0.2 million of pre-acquisition contingencies have either been paid or specifically identified and accrued, leaving a balance of $1.7 million to settle any remaining contingencies.  We believe that there is no additional material exposure as any amounts determined to be owed as a result of the above noted litigation and contingencies will be covered by the escrow account.  If and when received, we agreed to pay to Nutra SA ninety percent of any funds received from the escrow account or treat the funds retained as a distribution from Nutra SA and reduce our ownership percentage accordingly.

SEGMENT_INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2015
SEGMENT INFORMATION [Abstract]
SEGMENT INFORMATION	NOTE 13. SEGMENT INFORMATION
	The tables below present segment information for the periods identified and provide reconciliations of segment information to total consolidated information (in thousands).
	Three Months Ended March 31, 2015	Corporate			USA			Brazil			Consolidated
	Revenues	$	-		$	5,062		$	4,597		$	9,659
	Cost of goods sold		-			3,412			5,193			8,605
	Gross profit		-			1,650			(596	)		1,054
	Depreciation and amortization (in selling, general and administrative)		(15	)		(393	)		(97	)		(505	)
	Other operating expense		(1,178	)		(1,452	)		(857	)		(3,487	)
	Income (loss) from operations	$	(1,193	)	$	(195	)	$	(1,550	)	$	(2,938	)
	Net income (loss) attributable to RiceBran Technologies shareholders	$	(1,152	)	$	(195	)	$	(1,655	)	$	(3,002	)
	Interest expense		294			-			505			799
	Depreciation (in cost of goods sold)		-			141			516			657
	Purchases of property		-			236			71			307
	Three Months Ended March 31, 2014	Corporate			USA			Brazil			Consolidated
	Revenues	$	-		$	4,993		$	2,691		$	7,684
	Cost of goods sold		-			3,377			2,893			6,270
	Gross profit		-			1,616			(202	)		1,414
	Depreciation and amortization (in selling, general and administrative)		(10	)		(638	)		(170	)		(818	)
	Other operating expense		(1,632	)		(742	)		(941	)		(3,315	)
	Income (loss) from operations	$	(1,642	)	$	236		$	(1,313	)	$	(2,719	)
	Net income (loss) attributable to RiceBran Technologies shareholders	$	(988	)	$	236		$	(1,113	)	$	(1,865	)
	Interest expense		530			-			658			1,188
	Depreciation (in cost of goods sold)		-			253			424			677
	Purchases of property		84			143			1,976			2,203
	The tables below present segment information for selected balance sheet accounts (in thousands).
		Corporate			USA			Brazil			Consolidated
	As of March 31, 2015
	Inventories	$	-		$	2,972		$	1,298		$	4,270
	Property, net		440			8,911			12,085			21,436
	Goodwill		-			790			3,006			3,796
	Intangible assets, net		-			2,298			-			2,298
	Total assets		3,073			17,139			19,443			39,655
	As of December 31, 2014
	Inventories		-			2,219			1,289			3,508
	Property, net		135			9,360			15,258			24,753
	Goodwill		-			790			3,641			4,431
	Intangible assets, net		-			2,658			82			2,740
	Total assets		4,212			17,854			24,018			46,084
	Corporate segment total assets include cash, restricted cash, property and other assets.
	The following table presents revenue by geographic area for the three months ended March 31, 2015 and 2014 (in thousands).
		2015			2014
	United States	$	4,962		$	4,500
	Brazil		3,083			2,648
	Other international		1,614			536
	Total revenues	$	9,659		$	7,684

FAIR_VALUE_MEASUREMENT

FAIR VALUE MEASUREMENT	3 Months Ended
	Mar. 31, 2015
FAIR VALUE MEASUREMENT [Abstract]
FAIR VALUE MEASUREMENT	NOTE 14. FAIR VALUE MEASUREMENT
	The fair value of cash and cash equivalents, accounts and other receivables and accounts payable approximates their carrying value due to their shorter maturities.  As of March 31, 2015, the fair value of our USA segment debt (Level 3 measurement) is approximately $0.3 million higher than the $5.3 million carrying value of that debt, based on current market rates for similar debt with similar maturities.  The fair value of our Brazil segment debt (Level 3 measurement) approximates the carrying value of that debt based on the current market rates for similar debt with similar maturities.
	Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  Certain assets and liabilities are presented in the financial statements at fair value.  Assets and liabilities measured at fair value on a recurring basis include derivative warrant and conversion liabilities.  Assets and liabilities measured at fair value on a non-recurring basis may include property.
	We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:
		●	Level 1 – inputs include quoted prices for identical instruments and are the most observable.
		●	Level 2 – inputs include quoted prices for similar assets and observable inputs such as interest rates, currency exchange rates and yield curves.
		●	Level 3 – inputs are not observable in the market and include management’s judgments about the assumptions market participants would use in pricing the asset or liability.
	For instruments measured using Level 3 inputs, a reconciliation of the beginning and ending balances is disclosed.
	The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands):
			Level 1			Level 2			Level 3			Total
	Total liabilities at fair value, as of March 31, 2015 - derivative warrant liabilities		$	-		$	-		$	(782	)	$	(782	)
	Total liabilities at fair value, as of December 31, 2014 - derivative warrant liabilities		$	-		$	-		$	(955	)	$	(955	)
	Warrants accounted for as derivative liabilities are valued using the lattice model each reporting period and the resultant change in fair value is recorded in the statements of operations.  The lattice model requires us to assess the probability of future issuance of equity instruments at a price lower than the current exercise price of the warrants.  The risk-free interest rate is determined by reference to the treasury yield curve rate of instruments with the same term as the warrant.  Additional assumptions that were used to calculate fair value follow.
			31-Mar-15			31-Dec-14
	Risk-free interest rate			0.20%			0.1% - 1.0%
						(0.7% weighted average)
	Expected volatility			80.7% - 91.2%			95%
			(88.2% weighted average)
	The following tables summarize the changes in level 3 items measured at fair value on a recurring basis (in thousands):
			Fair Value as			Total			Issuance of			Fair Value, at			Change in
			of Beginning			Realized and			New			End of Period			Unrealized
			of Period			Unrealized			Instruments						Gains
						Gains									(Losses) on
						(Losses)									Instruments
															Still Held
							(1	)
	Three Months Ended March 31, 2015
	Derivative warrant liability		$	(955	)	$	173		$	-		$	(782	)	$	173
	Derivative conversion liability			-			-			-			-			-
	Total Level 3 fair value		$	(955	)	$	173		$	-		$	(782	)	$	173
	Three Months Ended March 31, 2014
	Derivative warrant liability		$	(1,685	)	$	1,555		$	(4,991	)	$	(5,121	)	$	1,555
	Derivative conversion liability			-			503			(589	)		(86	)		503
	Total Level 3 fair value		$	(1,685	)	$	2,058		$	(5,580	)	$	(5,207	)	$	2,058
		-1	Included in change in fair value of derivative warrant and conversion liabilities in our consolidated statements of operations.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2015
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 15. RELATED PARTY TRANSACTIONS
	Transactions with Baruch Halpern
	Entities beneficially owned by Baruch Halpern, a director, invested $2.6 million in our subordinated convertible notes and related warrants in 2012.  The terms of the notes beneficially owned by Mr. Halpern were modified in the fourth quarter of 2013.  In the three months ended March 31, 2015 and 2014 we paid less than $0.1 million of interest on subordinated notes beneficially owned by Mr. Halpern.
	Transactions with W. John Short
	W. John Short, our chief executive officer and director, invested in our subordinated convertible notes and related warrants $25 thousand in January 2012 and $25 thousand in April 2013.  The terms of the notes beneficially owned by Mr. Short were modified in the fourth quarter of 2013.  In the three months ended March 31, 2015 and 2014 we paid less than $1 thousand of interest on subordinated notes beneficially owned by Mr. Short.

INCOME_TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2015
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 16. INCOME TAXES
	Due to offerings and conversions occurring between December 2013 and May 2014, we believe our ability to utilize previously accumulated net operating loss carryforwards are subject to substantial annual limitations due to “change in ownership” provisions of the Internal Revenue Code of 1986, as amended, and similar state regulations.  Therefore in 2014, we recorded the impact of the expiration of substantial net operating loss carryforwards prior to utilization.  We have not yet finalized the exact amount of such limitation, as the rules in this area are complex, and our estimate of the annual limitation is subject to change.

CONCENTRATION_OF_CREDIT_RISK

CONCENTRATION OF CREDIT RISK	3 Months Ended
	Mar. 31, 2015
CONCENTRATION OF CREDIT RISK [Abstract]
CONCENTRATION OF CREDIT RISK	NOTE 17. CONCENTRATION OF CREDIT RISK
	One USA segment customer accounted for approximately 28% of our consolidated revenues for the three months ended March 31, 2015 and 27% of our consolidated revenues for the three months ended March 31, 2014.  This customer accounted for approximately 2% and 3% of our consolidated accounts receivable balances at March 31, 2015 and 2014, respectively.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2015
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 18. SUBSEQUENT EVENT
	On May 12, 2015, we entered into an $8 million senior secured credit facility agreement with a lender consisting of a $3.5 million maximum working capital revolver and two term loan tranches. The credit facility will mature on June 1, 2018, with the potential for two one-year maturity extensions. As part of the agreement, the lender received warrants to purchase 300,000 shares of our stock at a strike price of $5.25, exercisable over a five year term.  This credit facility will be subject to certain financial and non-financial covenants.
	As a result of the financing transaction, a majority of the subordinated note holders representing approximately 97% of the principal due have agreed to extend the maturity date of their notes to June 1, 2018. The interest rate will increase to 11.75% and the participating subordinated noteholders will receive 289,670 warrants cumulatively.

BASIS_OF_PRESENTATION_Policies

BASIS OF PRESENTATION (Policies)	3 Months Ended
	Mar. 31, 2015
BASIS OF PRESENTATION [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on revenue from contracts with customers, which supersedes current revenue recognition guidance and most industry-specific guidance.  Under the new standard we will recognize revenue from the transfer of goods or services to customers in amounts that reflect the consideration to which we expect to be entitled in exchange for those goods or services.  Revenue from a contract that contains multiple performance obligations will be allocated to each performance obligation generally on a relative standalone selling price basis.  The guidance is effective for our annual and interim periods beginning in 2017.  Early adoption is prohibited.  We have not yet determined the impact that the new guidance will have on our results of operations and financial position and have not yet determined the method by which we will adopt the standard in 2017.
	In February 2015, the FASB issued guidance which makes targeted amendments to current consolidation guidance.  Among other things, the standard changes the manner in which we would assess one of the characteristics of variable interest entities (VIEs) and introduces a separate analysis specific to limited partnerships and similar entities (such as Nutra SA) for assessing if the equity holders at risk lack decision making.  Limited partnerships and similar entities will be a VIE unless the limited partners hold substantive kick-out rights or participating rights.  A right to liquidate an entity is akin to a kick-out right.  Guidance for limited partnerships under the voting model has been eliminated.  A limited partner and similar partners with a controlling financial interest obtained through substantive kick-out rights would consolidate a limited partnership or similar entity. The guidance is effective for our annual and interim periods beginning in 2016.  Early adoption is allowed.  We have not yet determined the impact that the new guidance will have on our results of operations and financial position and have not yet determined if we will early adopt the standard.
	In April 2015, the FASB issued guidance on the presentation and disclosure of debt issuance costs. The update requires debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015. Early adoption permitted for financial statements that have not been previously issued. The adoption of this statement will impact future presentation and disclosures of the financial statements.

LOSS_PER_SHARE_EPS_Tables

LOSS PER SHARE (EPS) (Tables)	3 Months Ended
	Mar. 31, 2015
LOSS PER SHARE (EPS) [Abstract]
Reconciliations of numerators and denominators in EPS computations	Below are reconciliations of the numerators and denominators in the EPS computations for the three months ended March 31, 2015 and 2014.
		2015			2014
	NUMERATOR (in thousands):
	Basic and diluted - net loss attributable to RiceBran Technologies shareholders	$	(3,002	)	$	(1,865	)
	DENOMINATOR:
	Basic EPS - weighted average number of shares outstanding		9,154,134			3,017,408
	Effect of dilutive securities outstanding		-			-
	Diluted EPS - weighted average number of shares outstanding		9,154,134			3,017,408
	Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive-
	Stock options (average exercise price of $11.48 and $24.52)		264,305			174,141
	Warrants  (average exercise price of $5.77 and $6.27)		6,503,959			2,750,335
	Nonvested stock		224,967			-

HN_ACQUISITION_Tables

H&N ACQUISITION (Tables)	3 Months Ended
	Mar. 31, 2015
H&N ACQUISITION [Abstract]
Schedule of aggregate purchase price allocation	The following table summarizes the aggregate purchase price allocation, the consideration transferred to acquire HN, as well as the amounts of identified assets acquired and liabilities assumed based on the estimated fair value as of the January 2, 2014, acquisition date (in thousands).
	Cash	$	1,800
	Cash holdback for contingencies		200
	Convertible notes payable		2,785
	Total fair value of consideration transferred		4,785
	Financial assets, including acquired cash of $1,075		1,314
	Inventories		1,109
	Property		963
	Identified intangible asset estimate		3,847
	Deferred  income taxes, net		(1,529	)
	Financial liabilities		(1,709	)
	Net recognized amounts of identifiable assets acquired		3,995
	Goodwill - USA segment	$	790

REDEEMABLE_NONCONTROLLING_INTE1

REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA (Tables)	3 Months Ended
	Mar. 31, 2015
REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA [Abstract]
Summary of the carrying amounts included in consolidated balance sheets	A summary of the carrying amounts of Nutra SA balances included in our consolidated balance sheets follows (in thousands).
		March 31,			December 31,
		2015			2014
	Cash and cash equivalents	$	37		$	269
	Other current assets (restricted $1,727 and $1,980)		4,286			4,735
	Property, net (restricted $2,945 and  $3,727)		12,085			15,258
	Goodwill and intangibles, net		3,006			3,722
	Other noncurrent assets		29			34
	Total assets	$	19,443		$	24,018
	Current liabilities	$	5,637		$	5,346
	Current portion of long-term debt (nonrecourse)		3,877			4,758
	Long-term debt, less current portion (nonrecourse)		5,022			6,203
	Total liabilities	$	14,536		$	16,307
Summary of changes in redeemable noncontrolling interest	A summary of changes in redeemable noncontrolling interest in Nutra SA follows for the three months ended March 31, 2015 and 2014 (in thousands).
		2015			2014
	Redeemable noncontrolling interest in Nutra SA, beginning of period	$	2,643		$	7,177
	Investors' interest in net loss of Nutra SA		(644	)		(920	)
	Investors' interest in other comprehensive loss of Nutra SA		(481	)		168
	Accumulated Yield classified as other current liability		(142	)		-
	Redeemable noncontrolling interest in Nutra SA, end of period	$	1,376		$	6,425
	Investors' average interest in Nutra SA		34.2	%		45.2	%

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2015
INVENTORIES [Abstract]
Inventories	Inventories are composed of the following (in thousands):
		March 31,		December 31,
		2015		2014
	Finished goods	$	2,674	$	1,103
	Work in process		131		380
	Raw materials		966		1,441
	Packaging supplies		499		584
	Total inventories	$	4,270	$	3,508

PROPERTY_Tables

PROPERTY (Tables)	3 Months Ended
	Mar. 31, 2015
PROPERTY [Abstract]
Property, plant and equipment	Property, plant and equipment consist of the following (in thousands):
		March 31,		December 31,
		2015		2014
	Land	$	477	$	364
	Furniture and fixtures		449		539
	Plant		15,631		15,942
	Computer and software		1,871		1,701
	Leasehold improvements		637		568
	Machinery and equipment		22,854		21,519
	Property		41,919		40,633
	Less accumulated depreciation		20,483		15,880
	Property,  net	$	21,436	$	24,753

GOODWILL_Tables

GOODWILL (Tables)	3 Months Ended
	Mar. 31, 2015
GOODWILL [Abstract]
Summary of goodwill activity	A summary of goodwill activity follows for the three months ended March 31, 2015 and 2014.
		2015			2014
	Goodwill, beginning of period	$	4,431		$	4,139
	USA Segment - Acquisition of H&N		-			675
	Brazil segment - Effect of foreign currency translation		(635	)		179
	Goodwill, end of period	$	3,796		$	4,993

EQUITY_SHAREBASED_COMPENSATION1

EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS (Tables)	3 Months Ended
	Mar. 31, 2015
EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS [Abstract]
Summary of equity activity	A summary of equity activity for the three months ended March 31, 2015, (in thousands, except share and per share data) follows.
		Common Stock					Accumulated			Accumulated Other Comprehensive			Total
		Shares			Amount		Deficit			Loss			Equity
	Balance, December 31, 2014		9,383,571		$	261,299	$	(242,470	)	$	(3,157	)	$	15,672
	Share-based compensation, employees and directors		-			205		-			-			205
	Other		3,251			14		-			-			14
	Foreign currency translation		-			-		-			(937	)		(937	)
	Net loss		-			-		(3,002	)		-			(3,002	)
	Balance, March 31, 2015		9,386,822		$	261,518	$	(245,472	)	$	(4,094	)	$	11,952
Summary of stock option and warrant activity	A summary of stock option and warrant activity for the three months ended March 31, 2015, follows.
		Options								Equity and Liability Warrants
		Shares Under			Weighted		Weighted			Shares Under			Weighted			Weighted
		Options			Average		Average			Warrants			Average			Average
					Exercise		Remaining						Exercise			Remaining
					Price		Contractual						Price			Contractual
							Life (Years)									Life (Years)
	Outstanding, December 31, 2014		269,642		$	12.12		7.9			6,503,959		$	5.77			4.3
	Granted		-			-					-			-
	Exercised		-			-					-			-
	Forfeited, expired or cancelled		(15,000	)		23.18					-			-
	Outstanding, March 31, 2015		254,642		$	11.47		7.7			6,503,959		$	5.77			4.1
	Exercisable, March 31, 2015		144,141		$	16.15		6.4			5,322,264		$	5.88			3.8

DEBT_Tables

DEBT (Tables)	3 Months Ended
	Mar. 31, 2015
DEBT [Abstract]
Current and long-term debt	The following table summarizes current and long-term portions of debt (in thousands).
		March 31,		December 31,
		2015		2014
	Corporate segment:
	Subordinated notes, net	$	5,186	$	4,978
	Other		144		157
			5,330		5,135
	Brazil segment:
	Capital expansion loans		2,876		3,629
	Working capital lines of credit		1,811		2,408
	Advances on customer export orders		1,557		1,810
	Special tax programs		2,585		3,016
	Other		69		98
			8,898		10,961
	Total debt		14,228		16,096
	Current portion		3,931		4,808
	Long-term portion	$	10,297	$	11,288

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2015
SEGMENT INFORMATION [Abstract]
Segment information identified and reconciliations of segment information to total consolidated information	Three Months Ended March 31, 2015	Corporate			USA			Brazil			Consolidated
	Revenues	$	-		$	5,062		$	4,597		$	9,659
	Cost of goods sold		-			3,412			5,193			8,605
	Gross profit		-			1,650			(596	)		1,054
	Depreciation and amortization (in selling, general and administrative)		(15	)		(393	)		(97	)		(505	)
	Other operating expense		(1,178	)		(1,452	)		(857	)		(3,487	)
	Income (loss) from operations	$	(1,193	)	$	(195	)	$	(1,550	)	$	(2,938	)
	Net income (loss) attributable to RiceBran Technologies shareholders	$	(1,152	)	$	(195	)	$	(1,655	)	$	(3,002	)
	Interest expense		294			-			505			799
	Depreciation (in cost of goods sold)		-			141			516			657
	Purchases of property		-			236			71			307
	Three Months Ended March 31, 2014	Corporate			USA			Brazil			Consolidated
	Revenues	$	-		$	4,993		$	2,691		$	7,684
	Cost of goods sold		-			3,377			2,893			6,270
	Gross profit		-			1,616			(202	)		1,414
	Depreciation and amortization (in selling, general and administrative)		(10	)		(638	)		(170	)		(818	)
	Other operating expense		(1,632	)		(742	)		(941	)		(3,315	)
	Income (loss) from operations	$	(1,642	)	$	236		$	(1,313	)	$	(2,719	)
	Net income (loss) attributable to RiceBran Technologies shareholders	$	(988	)	$	236		$	(1,113	)	$	(1,865	)
	Interest expense		530			-			658			1,188
	Depreciation (in cost of goods sold)		-			253			424			677
	Purchases of property		84			143			1,976			2,203
Segment information for selected balance sheet accounts	The tables below present segment information for selected balance sheet accounts (in thousands).
		Corporate			USA			Brazil			Consolidated
	As of March 31, 2015
	Inventories	$	-		$	2,972		$	1,298		$	4,270
	Property, net		440			8,911			12,085			21,436
	Goodwill		-			790			3,006			3,796
	Intangible assets, net		-			2,298			-			2,298
	Total assets		3,073			17,139			19,443			39,655
	As of December 31, 2014
	Inventories		-			2,219			1,289			3,508
	Property, net		135			9,360			15,258			24,753
	Goodwill		-			790			3,641			4,431
	Intangible assets, net		-			2,658			82			2,740
	Total assets		4,212			17,854			24,018			46,084
Revenue by geographic area	The following table presents revenue by geographic area for the three months ended March 31, 2015 and 2014 (in thousands).
		2015			2014
	United States	$	4,962		$	4,500
	Brazil		3,083			2,648
	Other international		1,614			536
	Total revenues	$	9,659		$	7,684

FAIR_VALUE_MEASUREMENT_Tables

FAIR VALUE MEASUREMENT (Tables)	3 Months Ended
	Mar. 31, 2015
FAIR VALUE MEASUREMENT [Abstract]
Fair values by input hierarchy of items measured at fair value on a recurring basis	The following tables summarize the fair values by input hierarchy of items measured at fair value on a recurring basis on our consolidated balance sheets (in thousands):
			Level 1			Level 2			Level 3			Total
	Total liabilities at fair value, as of March 31, 2015 - derivative warrant liabilities		$	-		$	-		$	(782	)	$	(782	)
	Total liabilities at fair value, as of December 31, 2014 - derivative warrant liabilities		$	-		$	-		$	(955	)	$	(955	)
Additional assumptions used to calculate fair value	Additional assumptions that were used to calculate fair value follow.
			31-Mar-15			31-Dec-14
	Risk-free interest rate			0.20%			0.1% - 1.0%
						(0.7% weighted average)
	Expected volatility			80.7% - 91.2%			95%
			(88.2% weighted average)
Changes in level 3 items measured at fair value	The following tables summarize the changes in level 3 items measured at fair value on a recurring basis (in thousands):
			Fair Value as			Total			Issuance of			Fair Value, at			Change in
			of Beginning			Realized and			New			End of Period			Unrealized
			of Period			Unrealized			Instruments						Gains
						Gains									(Losses) on
						(Losses)									Instruments
															Still Held
							(1	)
	Three Months Ended March 31, 2015
	Derivative warrant liability		$	(955	)	$	173		$	-		$	(782	)	$	173
	Derivative conversion liability			-			-			-			-			-
	Total Level 3 fair value		$	(955	)	$	173		$	-		$	(782	)	$	173
	Three Months Ended March 31, 2014
	Derivative warrant liability		$	(1,685	)	$	1,555		$	(4,991	)	$	(5,121	)	$	1,555
	Derivative conversion liability			-			503			(589	)		(86	)		503
	Total Level 3 fair value		$	(1,685	)	$	2,058		$	(5,580	)	$	(5,207	)	$	2,058
		-1	Included in change in fair value of derivative warrant and conversion liabilities in our consolidated statements of operations.

BUSINESS_Details

BUSINESS (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
BUSINESS [Abstract]
Number of reportable business segments	2
Number of locations in California	2
Number of locations in Louisiana	1
Number of locations in Lake Charles, Louisiana	1
Revenue from Human Food Products [Member] | USA Segment Revenue [Member]
Concentration Risk [Line Items]
Concentration risk, percentage (in hundredths)	81.00%
RBO Products [Member] | Brazil Segment Revenue [Member]
Concentration Risk [Line Items]
Concentration risk, percentage (in hundredths)	47.00%	39.00%

LIQUIDITY_AND_MANAGEMENTS_PLAN1

LIQUIDITY AND MANAGEMENT'S PLAN (Details) (Subsequent Event [Member], USD $)	0 Months Ended
In Millions, unless otherwise specified	12-May-15
	Tranche
Line of Credit Facility [Line Items]
Term loan tranches	2
Senior Secured Credit Facility [Member]
Line of Credit Facility [Line Items]
Credit facility agreement	8
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum working capital revolver	3.5

LOSS_PER_SHARE_EPS_Details

LOSS PER SHARE (EPS) (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
NUMERATOR [Abstract]
Basic and diluted - net loss attributable to RiceBran Technologies shareholders	($3,002)	($1,865)
DENOMINATOR [Abstract]
Basic EPS - weighted average number of shares outstanding (in shares)	9,154,134	3,017,408
Effect of dilutive securities outstanding (in shares)	0	0
Diluted EPS - weighted average number of shares outstanding (in shares)	9,154,134	3,017,408
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	264,305	174,141
Average exercise price of options (in dollars per share)	$11.48	$24.52
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	6,503,959	2,750,335
Average exercise price of warrants (in dollars per share)	$5.77	$6.27
Nonvested Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares of common stock which could be purchased with weighted average outstanding securities not included in diluted EPS because effect would be antidilutive (in shares)	224,967	0

HN_ACQUISITION_Details

H&N ACQUISITION (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jan. 02, 2014	Jan. 02, 2014	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition, Cost of Acquired Entity, Purchase Price [Abstract]
Goodwill - USA segment	$3,796,000	$4,993,000			$4,431,000	$4,139,000
Revenues	9,659,000	7,684,000
H and N [Member]
Business Acquisition [Line Items]
Amount of outstanding shares purchased	2,000,000
Amount payable through promissory note	3,300,000
Acquisition-related costs		300,000
Business Acquisition, Cost of Acquired Entity, Purchase Price [Abstract]
Cash			1,800,000	1,800,000
Cash holdback for contingencies			200,000	200,000
Convertible notes payable			2,785,000	2,785,000
Total fair value of consideration transferred				4,785,000
Financial assets, including acquired cash of $1,075			1,314,000	1,314,000
Inventories			1,109,000	1,109,000
Property			963,000	963,000
Identified intangible asset estimate			3,847,000	3,847,000
Deferred income taxes, net			-1,529,000	-1,529,000
Financial liabilities			-1,709,000	-1,709,000
Net recognized amounts of identifiable assets acquired			3,995,000	3,995,000
Goodwill - USA segment			790,000	790,000
Acquired cash			1,075,000
Amount payable upon resolution of certain contingencies			200,000	200,000
Fair value of trade receivables			100,000	100,000
Amortization expense	300,000
Revenues		2,500,000
H and N [Member] | Customer Relationships [Member]
Business Acquisition, Cost of Acquired Entity, Purchase Price [Abstract]
Acquired intangible assets	3,800,000
Amortization of intangible in 2014	1,700,000
Amortization of intangible in 2015	1,300,000
Amortization of intangible in 2016	$800,000

REDEEMABLE_NONCONTROLLING_INTE2

REDEEMABLE NONCONTROLLING INTEREST IN NUTRA SA (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	13-May-15	Dec. 31, 2014	Dec. 31, 2013
Summary of carrying amounts included in consolidated balance sheets [Abstract]
Cash and cash equivalents	$1,249,000	$4,798,000		$3,610,000	$5,091,000
Other current assets (restricted $1,727 and $1,980)	909,000			1,071,000
Property, net (restricted $2,945 and $3,727)	21,436,000			24,753,000
Other noncurrent assets	158,000			88,000
Total assets	39,655,000			46,084,000
Current liabilities	14,857,000			15,130,000
Current portion of long-term debt (nonrecourse)	3,931,000			4,808,000
Long-term debt, less current portion (nonrecourse)	10,297,000			11,288,000
Total liabilities	26,327,000			27,769,000
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Redeemable noncontrolling interest in Nutra SA, beginning of period				2,643,000
Redeemable noncontrolling interest in Nutra SA, end of period	1,376,000			2,643,000
Nutra SA [Member]
Summary of carrying amounts included in consolidated balance sheets [Abstract]
Cash and cash equivalents	37,000			269,000
Other current assets (restricted $1,727 and $1,980)	4,286,000			4,735,000
Property, net (restricted $2,945 and $3,727)	12,085,000			15,258,000
Goodwill and intangibles, net	3,006,000			3,722,000
Other noncurrent assets	29,000			34,000
Total assets	19,443,000			24,018,000
Current liabilities	5,637,000			5,346,000
Current portion of long-term debt (nonrecourse)	3,877,000			4,758,000
Long-term debt, less current portion (nonrecourse)	5,022,000			6,203,000
Total liabilities	14,536,000			16,307,000
Restricted portion of other current assets	1,727,000			1,980,000
Variable interest entity restricted portion of property, net	2,945,000			3,727,000
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Redeemable noncontrolling interest in Nutra SA, beginning of period	2,643,000	7,177,000
Investors' interest in net loss of Nutra SA	-644,000	-920,000
Investors' interest in other comprehensive loss of Nutra SA	-481,000	168,000
Accumulated Yield classified as other current liability	-142,000	0
Redeemable noncontrolling interest in Nutra SA, end of period	1,376,000	6,425,000
Investors' average interest in Nutra SA (in hundredths)	34.20%	45.20%
Irgovel [Member]
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Minimum EBITDA triggering default status	4,000,000
NutraCea [Member]
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Number of representatives in management committee	3
Number of representatives in management committee upon default	2
Investors [Member]
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Ownership percentage of noncontrolling owner (in hundredths)	33.90%			34.70%
Number of representatives in management committee	2
Number of representatives in management committee upon default	3
Investors [Member] | Nutra SA [Member]
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Yield earned beginning in January, 2014 (in hundredths)	4.00%
Accrued yield in other expense	700,000
Contributions to be made	1,100,000
Drag along right termination amount	50,000,000
Investors [Member] | Nutra SA [Member] | Subsequent Event [Member]
Summary of changes for redeemable noncontrolling interest [Roll Forward]
Contributions to be made			$200,000

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
INVENTORIES [Abstract]
Finished goods	$2,674	$1,103
Work in process	131	380
Raw materials	966	1,441
Packaging supplies	499	584
Total inventories	$4,270	$3,508

PROPERTY_Details

PROPERTY (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Property, Plant and Equipment [Line Items]
Property	$41,919,000	$40,633,000
Less accumulated depreciation	20,483,000	15,880,000
Property, net	21,436,000	24,753,000
Amount payable for capital expansion project additions	100,000
Land [Member]
Property, Plant and Equipment [Line Items]
Property	477,000	364,000
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property	449,000	539,000
Plant [Member]
Property, Plant and Equipment [Line Items]
Property	15,631,000	15,942,000
Computer and Software [Member]
Property, Plant and Equipment [Line Items]
Property	1,871,000	1,701,000
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property	637,000	568,000
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property	$22,854,000	$21,519,000

GOODWILL_Details

GOODWILL (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Goodwill [Roll Forward]
Beginning of period			$4,431	$4,139
Ending of period	3,796	4,993	4,431	4,139
USA Segment [Member]
Goodwill [Roll Forward]
Acquisition of H&N	0	675
Brazil Segment [Member]
Goodwill [Roll Forward]
Effect of foreign currency translation	($635)	$179

EQUITY_SHAREBASED_COMPENSATION2

EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at beginning of period	$15,672
Balance at beginning of period (in shares)	9,383,571
Share-based compensation, employees and directors	205
Other	14
Foreign currency translation	-937
Net loss	-3,002	-1,865
Balance at end of period	11,952
Balance at end of period (in shares)	9,386,822
Common Stock [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at beginning of period	261,299
Balance at beginning of period (in shares)	9,383,571
Share-based compensation, employees and directors	205
Share-based compensation, employees and directors (in shares)	0
Other (in shares)	3,251
Other	14
Foreign currency translation	0
Net loss	0
Balance at end of period	261,518
Balance at end of period (in shares)	9,386,822
Accumulated Deficit [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at beginning of period	-242,470
Share-based compensation, employees and directors	0
Other	0
Foreign currency translation	0
Net loss	-3,002
Balance at end of period	-245,472
Accumulated Other Comprehensive Loss [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at beginning of period	-3,157
Share-based compensation, employees and directors	0
Other	0
Foreign currency translation	-937
Net loss	0
Balance at end of period	($4,094)

EQUITY_SHAREBASED_COMPENSATION3

EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS, STOCK OPTION AND WARRANT ACTIVITY (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Options [Member]
Shares Under Options, Outstanding [Roll Forward]
Outstanding at beginning of period (in shares)	269,642
Granted (in shares)	0
Exercised (in shares)	0
Forfeited, expired or cancelled (in shares)	-15,000
Outstanding at end of period (in shares)	254,642	269,642
Exercisable at end of period (in shares)	144,141
Options, Weighted Average Exercise Price [Roll Forward]
Outstanding at beginning of period (in dollars per share)	$12.12
Granted (in dollars per share)	$0
Exercised (in dollars per share)	$0
Forfeited, expired or cancelled (in dollars per share)	$23.18
Outstanding at end of period (in dollars per share)	$11.47	$12.12
Exercisable at end of period (in dollars per share)	$16.15
Options, Additional Disclosures [Abstract]
Outstanding, weighted average remaining contractual life	7 years 8 months 12 days	7 years 10 months 24 days
Exercisable, weighted average remaining contractual life	6 years 4 months 24 days
Equity and Liability Warrants [Member]
Shares Under Warrants [Roll Forward]
Outstanding at beginning of period (in shares)	6,503,959
Granted (in shares)	0
Exercised (in shares)	0
Forfeited, expired or cancelled (in shares)	0
Outstanding at end of period (in shares)	6,503,959	6,503,959
Exercisable at end of period (in shares)	5,322,264
Equity and Liability Warrants Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at beginning of period (in dollars per share)	$5.77
Granted (in dollars per share)	$0
Exercised (in dollars per share)	$0
Forfeited, expired or cancelled (in dollars per share)	$0
Outstanding at end of period (in dollars per share)	$5.77	$5.77
Exercisable at end of period (in dollars per share)	$5.88
Equity and Liability Warrants, Additional Disclosures [Abstract]
Outstanding, weighted average remaining contractual life	4 years 1 month 6 days	4 years 3 months 18 days
Exercisable, weighted average remaining contractual life	3 years 9 months 18 days

EQUITY_SHAREBASED_COMPENSATION4

EQUITY, SHARE-BASED COMPENSATION AND LIABILITY WARRANTS, TEXT (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015
	Agreement
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Number of warrant agreements outstanding	2
Equity Incentive Plan 2014 [Member]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Initially reserved (in shares)	1,600,000
Term of options	10 years
Equity Incentive Plan 2014 [Member] | Director and Executive Officers [Member]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Granted (in dollars per share)	4.91
Compensation expense	0.2
Compensation expense not yet recognized	0.8
Period over which compensation expense is recognized	2 years 2 months 12 days
Equity Incentive Plan 2014 [Member] | Director and Executive Officers [Member] | Vesting in August 2015 [Member]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Granted (in shares)	52,412
Equity Incentive Plan 2014 [Member] | Director and Executive Officers [Member] | Vesting in August 2014 [Member]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Granted (in shares)	44,026
Equity Incentive Plan 2014 [Member] | Director and Executive Officers [Member] | Vesting in August 2017 [Member]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Line Items]
Granted (in shares)	185,182

DEBT_Details

DEBT (Details)

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Dec. 31, 2014

Mar. 31, 2015

Jul. 31, 2012

USD ($)

BRL

USD ($)

Corporate Segment [Member]

Corporate Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Subordinated Notes, Net [Member]

Subordinated Notes, Net [Member]

Other [Member]

Other [Member]

Other [Member]

Other [Member]

Capital Expansion Loans [Member]

Capital Expansion Loans [Member]

Capital Expansion Loans [Member]

Working Capital Lines of Credit [Member]

Working Capital Lines of Credit [Member]

Working Capital Lines of Credit [Member]

Working Capital Lines of Credit [Member]

Working Capital Lines of Credit [Member]

Advances on Customer Export Orders [Member]

Advances on Customer Export Orders [Member]

Advances on Customer Export Orders [Member]

Advances on Customer Export Orders [Member]

Advances on Customer Export Orders [Member]

Special Tax Programs [Member]

Special Tax Programs [Member]

Third Credit Agreement [Member]

Third Credit Agreement [Member]

USD ($)

USD ($)

USD ($)

USD ($)

Corporate Segment [Member]

Corporate Segment [Member]

Corporate Segment [Member]

Corporate Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

Brazil Segment [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

BRL

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

Average [Member]

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

Average [Member]

USD ($)

USD ($)

BRL

Debt Instrument [Line Items]

Total debt

$14,228,000

$16,096,000

$5,330,000

$5,135,000

$8,898,000

$10,961,000

$5,186,000

$4,978,000

$144,000

$157,000

$69,000

$98,000

$2,876,000

$3,629,000

$1,811,000

$2,408,000

$1,557,000

$1,810,000

$2,585,000

$3,016,000

Current portion

3,931,000

4,808,000

Long-term portion

10,297,000

11,288,000

Principal amount outstanding of subordinated notes

7,900,000

6,500,000

Stated annual interest rate (in hundredths)

5.00%

6.50%

6.50%

10.40%

34.80%

26.20%

5.00%

10.00%

9.60%

12.80%

5.50%

Maturity date of note

31-Jul-16

31-Dec-21

31-Dec-21

30-Sep-19

31-Jan-29

31-Jul-19

Average annual interest rate for accreting the notes up to face value (in hundredths)

22.70%

Available for working capital

1,500,000

Amount borrowed

1,700,000

Borrowing capacity, percentage of collateral, lower range limit (in hundredths)

30.00%

Borrowing capacity, percentage of collateral, upper range limit (in hundredths)

100.00%

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	0 Months Ended
In Millions, unless otherwise specified	Feb. 06, 2009	Mar. 31, 2015	Feb. 06, 2009
Sellers [Member]
Loss Contingencies [Line Items]
Amount of second installment on purchase agreement being withheld	$1		$1
Settelment receivable from arbitration	3.6
Amount held in escrow	2	1.9	2
Amount of escrow liability in accrued expenses		1.7
Pre-acquisition contingencies		0.2
Escrow balance available to settle remaining contingencies		1.7
Pending Litigation [Member] | Former Irgovel Stockholder David Resyng [Member]
Loss Contingencies [Line Items]
Damages sought by plaintiff		$3

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Segment information identified and reconciliations of segment information to total consolidated information [Abstract]
Revenues	$9,659	$7,684
Cost of goods sold	8,605	6,270
Gross profit	1,054	1,414
Depreciation and amortization (in selling, general and administrative)	-505	-818
Other operating expense	-3,487	-3,315
Income (loss) from operations	-2,938	-2,719
Net income (loss) attributable to RiceBran Technologies shareholders	-3,002	-1,865
Interest expense	799	1,188
Depreciation (in costs of goods sold)	657	677
Purchases of property	307	2,203
Segment information for selected balance sheet accounts [Abstract]
Inventories	4,270		3,508
Property, net	21,436		24,753
Goodwill	3,796	4,993	4,431	4,139
Intangible assets, net	2,298		2,740
Total assets	39,655		46,084
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	9,659	7,684
Corporate [Member]
Segment information identified and reconciliations of segment information to total consolidated information [Abstract]
Revenues	0	0
Cost of goods sold	0	0
Gross profit	0	0
Depreciation and amortization (in selling, general and administrative)	-15	-10
Other operating expense	-1,178	-1,632
Income (loss) from operations	-1,193	-1,642
Net income (loss) attributable to RiceBran Technologies shareholders	-1,152	-988
Interest expense	294	530
Depreciation (in costs of goods sold)	0	0
Purchases of property	0	84
Segment information for selected balance sheet accounts [Abstract]
Inventories	0		0
Property, net	440		135
Goodwill	0		0
Intangible assets, net	0		0
Total assets	3,073		4,212
Operating Segments [Member] | USA [Member]
Segment information identified and reconciliations of segment information to total consolidated information [Abstract]
Revenues	5,062	4,993
Cost of goods sold	3,412	3,377
Gross profit	1,650	1,616
Depreciation and amortization (in selling, general and administrative)	-393	-638
Other operating expense	-1,452	-742
Income (loss) from operations	-195	236
Net income (loss) attributable to RiceBran Technologies shareholders	-195	236
Interest expense	0	0
Depreciation (in costs of goods sold)	141	253
Purchases of property	236	143
Segment information for selected balance sheet accounts [Abstract]
Inventories	2,972		2,219
Property, net	8,911		9,360
Goodwill	790		790
Intangible assets, net	2,298		2,658
Total assets	17,139		17,854
Operating Segments [Member] | Brazil [Member]
Segment information identified and reconciliations of segment information to total consolidated information [Abstract]
Revenues	4,597	2,691
Cost of goods sold	5,193	2,893
Gross profit	-596	-202
Depreciation and amortization (in selling, general and administrative)	-97	-170
Other operating expense	-857	-941
Income (loss) from operations	-1,550	-1,313
Net income (loss) attributable to RiceBran Technologies shareholders	-1,655	-1,113
Interest expense	505	658
Depreciation (in costs of goods sold)	516	424
Purchases of property	71	1,976
Segment information for selected balance sheet accounts [Abstract]
Inventories	1,298		1,289
Property, net	12,085		15,258
Goodwill	3,006		3,641
Intangible assets, net	0		82
Total assets	19,443		24,018
Reportable Geographic Segment [Member] | USA [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	4,962	4,500
Reportable Geographic Segment [Member] | Brazil [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	3,083	2,648
Reportable Geographic Segment [Member] | Other International [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$1,614	$536

FAIR_VALUE_MEASUREMENT_Details

FAIR VALUE MEASUREMENT (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt's excess value over carrying value	300,000
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]
Total liabilities at fair value	5,300,000
Derivative Warrant Liability [Member] | Recurring [Member]
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]
Total liabilities at fair value	-782,000	-955,000
Derivative Warrant Liability [Member] | Recurring [Member] | Minimum [Member]
Fair value assumptions [Abstract]
Risk-free interest rate (in hundredths)		0.10%
Expected volatility (in hundredths)	80.70%
Derivative Warrant Liability [Member] | Recurring [Member] | Maximum [Member]
Fair value assumptions [Abstract]
Risk-free interest rate (in hundredths)		1.00%
Expected volatility (in hundredths)	91.20%
Derivative Warrant Liability [Member] | Recurring [Member] | Weighted Average [Member]
Fair value assumptions [Abstract]
Risk-free interest rate (in hundredths)	0.20%	0.70%
Expected volatility (in hundredths)	88.20%	95.00%
Derivative Warrant Liability [Member] | Level 1 [Member] | Recurring [Member]
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]
Total liabilities at fair value	0	0
Derivative Warrant Liability [Member] | Level 2 [Member] | Recurring [Member]
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]
Total liabilities at fair value	0	0
Derivative Warrant Liability [Member] | Level 3 [Member] | Recurring [Member]
Fair values by input hierarchy of items measured at fair value on a recurring basis [Abstract]
Total liabilities at fair value	-782,000	-955,000

FAIR_VALUE_MEASUREMENT_Unobser

FAIR VALUE MEASUREMENT, Unobservable Input Reconciliation (Details) (Recurring [Member], USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Mar. 31, 2014
Changes in level 3 items measured at fair value on a recurring basis [Roll Forward]
Fair Value as of Beginning of Period	($955)		($1,685)
Total Realized and Unrealized Gains (Losses)	173	[1]	2,058	[1]
Issuance of New Instruments	0		-5,580
Fair Value, at End of Period	-782		-5,207
Change in Unrealized Gains (Losses) on Instruments Still Held	173		2,058
Derivative Warrant Liability [Member]
Changes in level 3 items measured at fair value on a recurring basis [Roll Forward]
Fair Value as of Beginning of Period	-955		-1,685
Total Realized and Unrealized Gains (Losses)	173	[1]	1,555	[1]
Issuance of New Instruments	0		-4,991
Fair Value, at End of Period	-782		-5,121
Change in Unrealized Gains (Losses) on Instruments Still Held	173		1,555
Derivative Conversion Liability [Member]
Changes in level 3 items measured at fair value on a recurring basis [Roll Forward]
Fair Value as of Beginning of Period	0		0
Total Realized and Unrealized Gains (Losses)	0	[1]	503	[1]
Issuance of New Instruments	0		-589
Fair Value, at End of Period	0		-86
Change in Unrealized Gains (Losses) on Instruments Still Held	$0		$503
[1]	Included in change in fair value of derivative warrant and conversion liabilities in our consolidated statements of operations.

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Apr. 30, 2013	Jan. 31, 2012
Related Party Transaction [Line Items]
Interest paid	$441	$580
Director - Baruch Halpern [Member] | Convertible Subordinated Debt [Member]
Related Party Transaction [Line Items]
Due to related parties	2,600
Interest paid	100	100
Chief Executive Officer and Director [Member] | Convertible Subordinated Debt [Member]
Related Party Transaction [Line Items]
Due to related parties			25	25
Interest paid	$1	$1

CONCENTRATION_OF_CREDIT_RISK_D

CONCENTRATION OF CREDIT RISK (Details) (One Customer [Member], USA [Member], Customer Concentration Risk [Member])	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenue [Member]
Concentration Risk [Line Items]
Concentration risk, percentage (in hundredths)	28.00%	27.00%
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration risk, percentage (in hundredths)	2.00%	2.00%

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	0 Months Ended	3 Months Ended
In Millions, except Share data, unless otherwise specified	12-May-15	Mar. 31, 2015
Subsequent Event [Line Items]
Exercisable period	5 years
Subsequent Event [Member]
Subsequent Event [Line Items]
Number of loan tranches	2
Maturity time period of credit facility	3 years
Warrants to purchase (in shares)	300,000
Stock at a strike price (in dollar per share)	5.25
Subsequent Event [Member] | Subordinated Notes [Member]
Subsequent Event [Line Items]
Debt maturity date		1-Jun-18
Percentage of note holders who agreed to extend maturity date (in hundredths)	97.00%
Subordinated note interest rate (in hundredths)	11.75%
Cummulative number of warrants subordinated note holders to receive (in shares)	289,670
Subsequent Event [Member] | Senior Secured Credit Facility [Member]
Subsequent Event [Line Items]
Secured credit facility agreement	8
Debt maturity date		1-Jun-18
Subsequent Event [Member] | Revolving Credit Facility [Member]
Subsequent Event [Line Items]
Maximum working capital	3.5